Vowst's FDA approval is a boon for the prevention of recurrent Clostridioides difficile infection.
Anand A, Parveen Shaikh N, Aggarwal Y, Fatima U, Chapagain S, Chidurala R, Vaghela J, Surana A, Parikh C, Patel RH.
Anand A, et al. Among authors: fatima u.
Ann Med Surg (Lond). 2023 Oct 17;85(12):5852-5854. doi: 10.1097/MS9.0000000000001410. eCollection 2023 Dec.
Ann Med Surg (Lond). 2023.
PMID: 38098563
Free PMC article.
No abstract available.